Mechanism discovered that controls the development of myelodysplastic syndromes

Researchers at the Moffitt Cancer Center have discovered a control mechanism that can trigger the development of myelodysplastic syndromes (MDS), a group of blood cancers. This finding may lead to therapies capable of preventing the progression of these diseases.MDS primarily affects older individuals, with approximately 12,000 new cases diagnosed each year. In MDS, a person's blood is not able to make one or more types of healthy blood cells - red blood cells, white blood cells or platelets. Instead, the patient has a high number of immature stem cells that do not develop properly.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Blood / Hematology Source Type: news